EC Proposes New GMP Rules Aimed at Counterfeits

Pharmaceutical manufacturers marketing drugs in Europe must verify that the starting materials they use to make products are produced in accordance with good manufacturing practices (GMPs), according to legislation proposed last month by the European Commission (EC). Manufacturing authorization holders must verify the GMP compliance of their active substances suppliers either on their own or through an accredited organization under the legislation.
Drug GMP Report